Prostate cancer is one of the most common diagnosed cancers in men and the waiting time has become an important issue not only for clinical reasons, but also mostly for the psychological implications on patients. The aim of our study was to review and analyze the literature on waiting times for prostate cancer. In February-March 2019 we performed a search for original peer-reviewed papers in the electronic database PubMed (MEDLINE). The key search terms were “prostate cancer AND waiting list”, “prostate cancer AND waiting times”. We included in our narra-tive review articles in Italian, English or French, published in 2009-2019 containing original data about the waiting times for prostate cancer. The literature search yielded 680 publicatio...
Journal Article;BACKGROUND Little is known about the healthcare process for patients with prostate ...
A recent publication in your journal, involving 619 Canadian patients undergoing radical prostatecto...
Following widespread introduction of prostate-specific antigen (PSA) testing, prostate cancer incide...
Prostate cancer is one of the most common diagnosed cancers in men and the waiting time has become a...
Prostate cancer is one of the most common diagnosed cancer in men and the waiting time has become an...
BACKGROUND: Prostate cancer (PCa) is the second most common neoplasm in male patients. To date, ther...
Background: Prostate cancer is the second most common reason of mortality due to cancer among men in...
Executive Summary Prostate cancer is the most common malignancy in men, and the third highest cancer...
Prostate cancer is one of the most common cancers in men. The incidence of prostate cancer increases...
PurposeWatchful waiting (WW) is one option for men with clinically localized prostate cancer. We exa...
Context: Delaying definitive therapy unfavourably affects outcomes in many malignancies. Diagnostic,...
Prostate cancer (PCa) is the second most common neoplasm in male patients. To date, there's no certa...
Prostate cancer is the most commonly diagnosed cancer and the second-leading cause of death from can...
Background: Wait times in cancer diagnosis and treatment may significantly affect a patient’s treatm...
Funding Information: This study was funded by The Swedish Cancer Society (CF2016/795 and 2018/765) a...
Journal Article;BACKGROUND Little is known about the healthcare process for patients with prostate ...
A recent publication in your journal, involving 619 Canadian patients undergoing radical prostatecto...
Following widespread introduction of prostate-specific antigen (PSA) testing, prostate cancer incide...
Prostate cancer is one of the most common diagnosed cancers in men and the waiting time has become a...
Prostate cancer is one of the most common diagnosed cancer in men and the waiting time has become an...
BACKGROUND: Prostate cancer (PCa) is the second most common neoplasm in male patients. To date, ther...
Background: Prostate cancer is the second most common reason of mortality due to cancer among men in...
Executive Summary Prostate cancer is the most common malignancy in men, and the third highest cancer...
Prostate cancer is one of the most common cancers in men. The incidence of prostate cancer increases...
PurposeWatchful waiting (WW) is one option for men with clinically localized prostate cancer. We exa...
Context: Delaying definitive therapy unfavourably affects outcomes in many malignancies. Diagnostic,...
Prostate cancer (PCa) is the second most common neoplasm in male patients. To date, there's no certa...
Prostate cancer is the most commonly diagnosed cancer and the second-leading cause of death from can...
Background: Wait times in cancer diagnosis and treatment may significantly affect a patient’s treatm...
Funding Information: This study was funded by The Swedish Cancer Society (CF2016/795 and 2018/765) a...
Journal Article;BACKGROUND Little is known about the healthcare process for patients with prostate ...
A recent publication in your journal, involving 619 Canadian patients undergoing radical prostatecto...
Following widespread introduction of prostate-specific antigen (PSA) testing, prostate cancer incide...